Human oesophageal adenocarcinoma cell lines JROECL 47 and JROECL 50 are admixtures of the human colon carcinoma cell line HCT 116 by Wijnhoven, B P L et al.
1510
Recently, four human oesophageal and gastric cardia adenocarci-
noma cell lines were established (Rockett et al, 1997). These cell
lines were included in two studies on E-cadherin and b-catenin
gene mutations in adenocarcinomas of the oesophagus
(Wijnhoven et al, 1999; Wijnhoven et al, 2000). Cell lines
JROECL 47 and JROECL 50, derived from one tumour, harbour
E-cadherin and b-catenin gene mutations. These mutations could
not be detected in the primary tumour from which the cell lines
were established. Recently, identical E-cadherin and b-catenin
gene mutations have been described in the human colon tumour
cell line HCT 116, established in 1981 (Brattain et al, 1981;
Efstathiou et al, 1999; Ilyas et al, 1997). These results prompted us
to investigate the derivation of the cell lines JROECL 47 and
JROECL 50 by HLA-typing, mutation analyses, microsatellite
allelotyping and microsatellite instability (MSI) analysis.
MATERIALS AND METHODS
Cell lines, primary tumour, xenografts and DNA
isolation
Cell lines JROECL 47 (passage 16) and JROECL 50 (passage 10)
were obtained from the European Collection of Cell Cultures
(ECACC). From cell lines JROECL 47 and JROECL 50 the early
passages, before submission of these cell lines to the ECACC
(passages 2 and 4, respectively) were also investigated. These
early passages were a gift from Dr AG Morris, University of
Warwick, Coventry, UK. Sections from the original paraffin tissue
blocks of the patient’s oesophageal tumour, from which the cell
lines JROECL 47 and 50 were presumably derived, were gifted by
Dr SJ Darnton, Birmingham Heartlands Hospital, Birmingham,
UK. Colon cancer cell line HCT 116 was a generous gift from Dr
P van der Saag, Hubrecht Laboratory, Utrecht, the Netherlands.
Cells were cultured under standard conditions in RPMI 1640
supplemented with 10% FCS.
To study the histological characteristics, 5 ´ 106 trypsinized
tumour cells from cell lines JROECL 47 and 50 (passages 16 and
10, respectively) and HCT 116 were injected subcutaneously in
female NMRI nude mice. Xenografts were removed and routinely
processed for histological examination. The animal experiments
were licensed and done in accordance with approved protocols
by the Erasmus University Medical Centre, Rotterdam, The
Netherlands.
DNA was isolated by standard proteinase K digestion and
phenol extraction from the cultured cell lines and from the tissue
block of the original oesophageal tumour, from which cell lines
JROECL 47 and JROECL 50 were presumably established.
HLA typing
HLA-DRB1 typing was performed on cell lines JROECL 47 and
50, cell line HCT116 and the tissue blocks of the original tumour,
as described (McGinnis et al, 1995). The polymorphic exon 2 was
amplified and subsequently sequenced on an ABI373 automated
sequencer (Perkin Elmer, Foster City, USA). HLA-DRB allele
assignment was established by comparing the sequences obtained
to the HLA-allele database similar to HLA-DPB allele assignment
(Versluis et al, 1993).
Mutation analyses
Cell line HCT 116 has heterozygous mutations in the E-cadherin
gene (codon 120; exon 3), the b-catenin gene (codon 45; exon 3)
and the K-ras gene (codon 13; exon 1) (Buard et al, 1996;
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Efstathiou et al, 1999; Ilyas et al, 1997). PCR-SSCP was
performed to detect these mutations, as described (Buard et al,
1996; Fukuchi et al, 1998; Wijnhoven et al, 1999). Samples with
aberrant migrating bands were reamplified, cloned and sequenced.
Microsatellite analyses
Nine polymorphic dinucleotide repeat markers: D8S136, D8S133,
D9S161, D9S156, D16S265, D14S292, D14S977, D17S786 and
CHRNB1 were investigated by radioactive PCR as described
previously (Trapman et al, 1994).
Because HCT 116 is reported to have the microsatellite instable
(MSI) phenotype (Hoang et al, 1997), MSI markers BAT26,
BAT40 and BAT-RII were also investigated (Grady et al, 1998).
RESULTS AND DISCUSSION
To date, only very few in vitro growing human oesophageal
adenocarcinoma cell lines are known. The availability of these cell
lines is of great value to study the biology and the genetic alter-
ations in these poorly-understood cancers, which show a dramatic
increase in incidence over the past decades (McKinney et al,
1995). Recently, four such cell lines were established (Rockett
et al, 1997). Here we report that two of these cell lines, JROECL
47 and JROECL 50 are in fact admixtures of the human colon
cancer cell line HCT 116.
In all experiments identical results were obtained for the early
and late passages of cell lines JROECL 47 and JROECL 50. In cell
culture JROECL 47, JROECL 50 and HCT 116 have the same
morphology with spindle shaped cells and similar growth rates.
Xenografting of these three cell lines resulted in undifferentiated
solid tumours, without glandular differentiation (results not
shown). HLA typing revealed that cell lines JROECL 47,
JROECL 50 and HCT 116 all have the same HLA-DR allele
DRB1 *03011/1102, which is different from the original primary
oesophageal tumour from which the cell lines JROECL 47 and 50
were presumably established: DRB1 *08032/04011. An example
of the difference between the cell lines and the original primary
tumour is shown by a characteristic sequence of exon 2 of the
primary tumour and the cell lines (Figure 1). The frequency of the
patient primary tumour allele combination DRB1 *08032/04011
in the population is less than 0.0041 compared to the frequency of
0.0098 of the allele combination DRB1*03011/1102 of the cell
lines (Schipper et al, 1996). Furthermore, PCR-SSCP analyses of
exon 3 of the E-cadherin gene, exon 3 of the b-catenin gene and
codon 12/13 of the K-ras gene showed an identical, aberrant
mobility pattern in all three cell lines (Figure 2). Upon sequencing
of the samples with aberrant migration patterns, the reported
mutations in all three genes were confirmed (results not shown)
(Buard et al, 1996; Efstathiou et al, 1999; Ilyas et al, 1997).
Allelotyping, however, showed different allele sizes between
the three cell lines with 7/9 polymorphic markers, indicating a
different origin of the cell lines (Figure 3A). With two markers the
allele patterns were identical between the cell lines. But all three
MSI markers demonstrated pronounced microsatellite instability
with different allele sizes in the three cell lines. Figure 3B repre-
sents an example of MSI in the three cell lines as demonstrated by
BAT26. Indeed, HCT 116 has been reported to have an extremely
microsatellite instable phenotype (Oki et al, 1999). Obviously,
separate cultures of HCT 116 resulted in different microsatellite
alterations. Therefore, microsatellite analysis is not appropriate for
allelotyping MSI cell lines.
Our assumption that cell lines JROECL 47 and 50 are admix-
tures of HCT 116 was confirmed by the ECACC with DNA finger-
printing (personal communication). Therefore, we conclude that
cell lines JROECL 47 and JROECL 50 are not human oesophageal
adenocarcinoma cell lines, but are admixtures of the human colon
adenocarcinoma cell line HCT 116.
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Figure 1 HLA-typing of the original primary tumour and the cell lines
(JROECL 47 and 50 and HCT 116). The polymorphic positions of HLA-DRB1
exon 2 are shown in vertical orientation. Dots indicate identity to the
nucleotide of the DRB1*08032 allele. Numbers are the polymorphic positions
of nucleotides in exon 2 shown in vertical orientation (position 28, 30, …
258). The polymorphic positions of the original primary tumour
(DRB1*08032/04011) have been compared with the cell lines. The alleles
present in the primary tumour do not exist in the cell lines.
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Figure 2 PCR-SSCP analysis of the E-cadherin gene exon 3 (A), b-catenin
gene exon 3 (B) and K-ras gene codon 12/13 (C). Lanes 1 and 5, normal,
non-mutated control DNA from one individual; lane 2, JROECL 47; lane 3,
JROECL 50 and lane 4, HCT 116. Note the same aberrant migration patterns
in all 3 cell lines (arrowheads), as compared to normal control DNA.
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Figure 3 Allelotyping with polymorphic marker CHRNB1 (A) and
microsatellite analysis with BAT26 (B). Lanes 1 and 5, normal control DNA
from one individual; lane 2, JROECL 47; lane 3, JROECL 50 and lane 4,
HCT 116. Note the different allele sizes in the three cell lines, indicating
different origins (A). Note the alteration in mononucleotide repeat size in the
cell line DNAs compared to normal, control DNA, indicating MSI (B).1512 BPL Wijnhoven et al
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Furthermore, allelotyping of cell lines by microsatellite analysis
can be hampered by MSI.
ACKNOWLEDGEMENTS
The authors thank H Sleddens, N Groen, AW van der Zwan,
E Rozemuller and NJ de Both for technical assistance.
REFERENCES
Brattain MG, Fine WD, Khaled FM, Thompson J and Brattain DE (1981)
Heterogeneity of malignant cells from a human colonic carcinoma. Cancer Res
41: 1751–1756
Buard A, Zipfel PA, Frey RS and Mulder KM (1996) Maintenance of growth factor
signaling through Ras in human colon carcinoma cells containing K-ras
mutations. Int J Cancer 67: 539–546
Efstathiou JA, Liu D, Wheeler JM, Kim HC, Beck NE, Ilyas M, Karayiannakis AJ,
Mortensen NJ, Kmiot W, Playford RJ, Pignatelli M and Bodmer WF (1999)
Mutated epithelial cadherin is associated with increased tumorigenicity and loss
of adhesion and of responsiveness to the motogenic trefoil factor 2 in colon
carcinoma cells. Proc Natl Acad Sci USA 96: 2316–2321
Fukuchi T, Sakamoto M, Tsuda H, Maruyama K, Nozawa S and Hirohashi S (1998)
Beta-catenin mutation in carcinoma of the uterine endometrium. Cancer Res
58: 3526–3528
Grady WM, Rajput A, Myeroff L, Liu DF, Kwon K, Willis J and Markowitz S
(1998) Mutation of the type II transforming growth factor-beta receptor is
coincident with the transformation of human colon adenomas to malignant
carcinomas. Cancer Res 58: 3101–3104
Hoang JM, Cottu PH, Thuille B, Salmon RJ, Thomas G and Hamelin R (1997)
BAT-26, an indicator of the replication error phenotype in colorectal cancers
and cell lines. Cancer Res 57: 300–303
Ilyas M, Tomlinson IP, Rowan A, Pignatelli M and Bodmer WF (1997) Beta-catenin
mutations in cell lines established from human colorectal cancers. Proc Natl
Acad Sci USA 94: 10330–10334
McGinnis MD, Conrad MP, Bouwens AG, Tilanus MG and Kronick MN (1995)
Automated, solid-phase sequencing of DRB region genes using T7 sequencing
chemistry and dye-labeled primers. Tissue Antigens 46: 173–179
McKinney A, Sharp L, Macfarlane GJ and Muir CS (1995) Oesophageal and gastric
cancer in Scotland 1960–90. Br J Cancer 71: 411–415
Oki E, Oda S, Maehara Y and Sugimachi K (1999) Mutated gene-specific
phenotypes of dinucleotide repeat instability in human colorectal carcinoma
cell lines deficient in DNA mismatch repair. Oncogene 18: 2143–2147
Rockett JC, Larkin K, Darnton SJ, Morris AG and Matthews HR (1997) Five newly
established oesophageal carcinoma cell lines: phenotypic and immunological
characterization. Br J Cancer 75: 258–263
Schipper RF, Schreuder GM, D’Amaro J and Oudshoorn M (1996) HLA gene and
haplotype frequencies in Dutch blood donors. Tissue Antigens 48:
562–574
Trapman J, Sleddens HF, van der Weiden MM, Dinjens WN, Konig JJ, Schroder FH,
Faber PW and Bosman FT (1994) Loss of heterozygosity of chromosome 8
microsatellite loci implicates a candidate tumor suppressor gene between the
loci D8S87 and D8S133 in human prostate cancer. Cancer Res 54:
6061–6064
Versluis LF, Rozemuller E, Tonks S, Marsh SG, Bouwens AG, Bodmer JG and
Tilanus MG (1993) High-resolution HLA-DPB typing based upon
computerized analysis of data obtained by fluorescent sequencing of the
amplified polymorphic exon 2. Hum Immunol 38: 277–283
Wijnhoven BP, de Both NJ, van Dekken H, Tilanus HW and Dinjens WN (1999)
E-cadherin gene mutations are rare in adenocarcinomas of the oesophagus.
Br J Cancer 80: 1652–1657
Wijnhoven BPL, Nollet F, de Both NJ, Tilanus HW and Dinjens WNM (2000).
Genetic alterations involving exon 3 of the beta-catenin gene do not play a role
in adenocarcinomas of the oesophagus. Int J Cancer (in press)